Rheumatoid Arthritis

Latest News

biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book - Image  credit: lexiconimages | stock.adobe.com
Organon Expands Portfolio With Biosimilar Tocilizumab-bavi for Arthritis and COVID-19

April 3rd 2025

Tocilizumab-bavi received FDA approval in September 2023 as the first biosimilar to tocilizumab for the treatment of various adult and pediatric arthritis conditions.

Updates on the Use of Biosimilars for Pediatric Patients With Rheumatic Disease
Updates on the Use of Biosimilars for Pediatric Patients With Rheumatic Disease

February 24th 2025

The drug is indicated for imultiple diseases, such as rheumatoid arthritis (RA), giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, and COVID-19.| Pawel | stock.adobe.com
FDA Approves Tocilizumab-Anoh as a Biosimilar to Actemra

January 31st 2025

Woman hand suffering from joint pain with gout in finger - Image credit: doucefleur | stock.adobe.com
SEL-212 Shows Promise in Treating Chronic Refractory Gout with High Response Rates

January 22nd 2025

Rheumatoid Arthritis, Obesity, BMI, Therapy | Image Credit: © yodiyim | stock.adobe.com
Higher BMI Associated With Risk of Discontinuation for Non–TNF-Targeted Therapy for Rheumatoid Arthritis

January 14th 2025

More News